Results 161 to 170 of about 6,081 (225)

Inotropic Support During Experimental Endotoxemic Shock: Part II. A Comparison of Levosimendan with Dobutamine

, 2009
Doris Cunha‐Goncalves, Valéria Perez‐de‐Sá, Anders Larsson, Johan Thörne, Sten Blomquist   +4 more
openalex   +1 more source

Levosimendan in Early Sepsis: When Good Ideas Give Poor Results

, 2009
Daniel De Backer, Hendrik Bracht
openalex   +1 more source

Effect of Levosimendan on Low Cardiac Output Syndrome After Pericardiectomy. [PDF]

Ther Clin Risk Manag
Fang L, Zhu P, Yu G, Lv W, Hu J.
europepmc   +1 more source

Comparative efficacy of different drugs in acute heart failure with renal dysfunction: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Lv Q, Wu Q, Yang Y, Li L, Ye X, Wang S, Lv Y, Wang M, Li Y.   +8 more
europepmc   +1 more source

Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis. [PDF]

Cochrane Database Syst Rev
Burkhardt BE, Hummel J, Rücker G, Stiller B.   +3 more
europepmc   +1 more source

Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery. [PDF]

J Cardiothorac Surg
Zhao M, Hou Y, Yuan M, Ma S, Yue Y.
europepmc   +1 more source

Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery. [PDF]

Cochrane Database Syst Rev
Gayatri D, Tongers J, Efremov L, Mikolajczyk R, Sedding D, Schumann J.   +5 more
europepmc   +1 more source

The current use of vasoactive agents in cardiogenic shock related to myocardial infarction and acute decompensated heart failure. [PDF]

Am Heart J Plus
Becerra AF, Amanamba U, Lopez JE, Blaker NJ, Winchester DE.   +4 more
europepmc   +1 more source

Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial. [PDF]

Catheter Cardiovasc Interv
Bosa Ojeda F, Méndez Vargas C, Lacalzada Almeida J, Izquierdo Gómez MM, Jiménez Sosa A, Rodríguez Jiménez C, Sánchez-Grande Flecha A, Bosa Santana M, Yanes Bowden G.   +8 more
europepmc   +1 more source